Case report: MR spectroscopy in pantothenate kinase-2 associated neurodegeneration
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Case report: MR spectroscopy in pantothenate kinase-2 associated neurodegeneration ; volume:20 ; number:03 ; year:2010 ; pages:188-191
The Indian journal of radiology and imaging ; 20, Heft 03 (2010), 188-191
- Contributor
-
Parashari, Umesh C.
Aga, Pallavi
Parihar, Anit
Singh, Ragini
Joshi, Vindhya
- DOI
-
10.4103/0971-3026.69353
- URN
-
urn:nbn:de:101:1-2021090211251130120622
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Parashari, Umesh C.
- Aga, Pallavi
- Parihar, Anit
- Singh, Ragini
- Joshi, Vindhya
Other Objects (12)
A therapeutic approach to pantothenate kinase associated neurodegeneration
Resting state networks alteration in pantothenate-kinase associated neurodegeneration (PKAN)
Diagnostic and clinical experience of patients with pantothenate kinase-associated neurodegeneration
A therapeutic approach to pantothenate kinase associated neurodegeneration: a pilot study
Genetic mutation spectrum of pantothenate kinase-associated neurodegeneration expanded by breakpoint sequencing in pantothenate kinase 2 gene
Neurodegeneration in SCA14 is associated with increased PKCγ kinase activity, mislocalization and aggregation
Therapeutic approach with commercial supplements for pantothenate kinase-associated neurodegeneration with residual PANK2 expression levels
Patient and caregiver experiences with pantothenate kinase-associated neurodegeneration (PKAN): results from a patient community survey
A new TAO kinase inhibitor reduces tau phosphorylation at sites associated with neurodegeneration in human tauopathies
Mitochondria-associated membranes as hubs for neurodegeneration
cGAS-STING triggers inflammaging-associated neurodegeneration
Biological function of Lemur tyrosine kinase 2 (LMTK2): implications in neurodegeneration
A therapeutic approach to pantothenate kinase associated neurodegeneration
Resting state networks alteration in pantothenate-kinase associated neurodegeneration (PKAN)
Diagnostic and clinical experience of patients with pantothenate kinase-associated neurodegeneration
A therapeutic approach to pantothenate kinase associated neurodegeneration: a pilot study
Genetic mutation spectrum of pantothenate kinase-associated neurodegeneration expanded by breakpoint sequencing in pantothenate kinase 2 gene
Neurodegeneration in SCA14 is associated with increased PKCγ kinase activity, mislocalization and aggregation
Therapeutic approach with commercial supplements for pantothenate kinase-associated neurodegeneration with residual PANK2 expression levels
Patient and caregiver experiences with pantothenate kinase-associated neurodegeneration (PKAN): results from a patient community survey
A new TAO kinase inhibitor reduces tau phosphorylation at sites associated with neurodegeneration in human tauopathies
Mitochondria-associated membranes as hubs for neurodegeneration
cGAS-STING triggers inflammaging-associated neurodegeneration
Biological function of Lemur tyrosine kinase 2 (LMTK2): implications in neurodegeneration
A therapeutic approach to pantothenate kinase associated neurodegeneration
Resting state networks alteration in pantothenate-kinase associated neurodegeneration (PKAN)
Diagnostic and clinical experience of patients with pantothenate kinase-associated neurodegeneration
A therapeutic approach to pantothenate kinase associated neurodegeneration: a pilot study
Genetic mutation spectrum of pantothenate kinase-associated neurodegeneration expanded by breakpoint sequencing in pantothenate kinase 2 gene
Neurodegeneration in SCA14 is associated with increased PKCγ kinase activity, mislocalization and aggregation
Therapeutic approach with commercial supplements for pantothenate kinase-associated neurodegeneration with residual PANK2 expression levels
Patient and caregiver experiences with pantothenate kinase-associated neurodegeneration (PKAN): results from a patient community survey
A new TAO kinase inhibitor reduces tau phosphorylation at sites associated with neurodegeneration in human tauopathies
Mitochondria-associated membranes as hubs for neurodegeneration
cGAS-STING triggers inflammaging-associated neurodegeneration